For instance, the different levels of CD8+ TIL densities that are evident among various cancers may serve as an indicator of the relative immune responsiveness of each tumor type, based on concepts of CD8 previously proposed [5, 15–17, 19, 20]. The gene discussed is CD8A; the disease is cancer.